Open Journal of Gastroenterology

Vol.8 No.6(2018), Paper ID 85297, 8 pages

DOI:10.4236/ojgas.2018.86022

 

The Effect of Loop Diuretics on Sarcopenia and Long-Term Prognosis in Patients with Refractory Hepatic Ascites Treated with Tolvaptan

 

Masaaki Shimada, Hiroaki Iwase, Noboru Hirashima, Masashi Saito, Hisashi Kondo, Noboru Urata, Satoshi Unita, Takashi Kondo, Daiki Tanaka, Takuya Tsunekawa

 

Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Department of Gastroenterology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan

 

Copyright © 2018 Masaaki Shimada, Hiroaki Iwase, Noboru Hirashima, Masashi Saito, Hisashi Kondo, Noboru Urata, Satoshi Unita, Takashi Kondo, Daiki Tanaka, Takuya Tsunekawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Shimada, M. , Iwase, H. , Hirashima, N. , Saito, M. , Kondo, H. , Urata, N. , Unita, S. , Kondo, T. , Tanaka, D. and Tsunekawa, T. (2018) The Effect of Loop Diuretics on Sarcopenia and Long-Term Prognosis in Patients with Refractory Hepatic Ascites Treated with Tolvaptan. Open Journal of Gastroenterology, 8, 201-208. doi: 10.4236/ojgas.2018.86022.

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.